A lot of people are watching the hemp industry right now with real concern. H.R. 5371 passed in late 2025, and enforcement kicks in November 12, 2026. If you buy delta-8 gummies, HHC vapes, or THCa products, your options are about to shrink fast. Many brands you know will either reformulate or disappear from shelves.
Wunder isn't one of them. Here's why, and what the law actually says.
What H.R. 5371 actually says
H.R. 5371, sometimes called the Farm Bill 2025 amendment, closes the loophole that let hemp processors sell psychoactive cannabinoids legally by keeping total delta-9 THC below 0.3% by dry weight. The bill bans hemp-derived intoxicants above that 0.3% threshold, regardless of which cannabinoid delivers the effect.
That means delta-8 THC, delta-10 THC, HHC, HHC-O, THCa (measured after decarboxylation), and related compounds are now explicitly prohibited under federal law. The 0.3% delta-9 exemption no longer applies to converted or synthetically derived cannabinoids.
Enforcement date: November 12, 2026. After that, manufacturers, distributors, and retailers selling these compounds face federal penalties under the Controlled Substances Act.
This is not a rumor or a gray area. The bill passed. The clock is running.
What products are affected
Any product containing hemp-derived cannabinoids that produce intoxication falls under this rule. The clearest examples:
- Delta-8 THC: derived from hemp CBD via chemical conversion, and the primary target of the bill
- Delta-10 THC: same conversion process, different compound
- HHC and HHC-O: hydrogenated THC derivatives, widely sold as delta-8 alternatives in recent years
- THCa: technically below the delta-9 limit in raw form, but converts to delta-9 when heated; the bill accounts for this
- Any other hemp-derived compound with psychoactive effects above 0.3% THC equivalent
Brands that built their product lines around these compounds face hard choices: reformulate, find a new supply chain, or exit the category entirely by November.
What is NOT affected by H.R. 5371
The bill targets hemp-derived cannabinoids. Full stop. It says nothing about botanical compounds from different plants entirely.
These are not affected:
- Kava (from the Piper methysticum plant): not hemp, not a cannabinoid, not covered
- Blue lotus (Nymphaea caerulea): an aquatic plant used in traditional wellness contexts
- Kanna (Sceletium tortuosum): a South African succulent
- Amanita muscaria extract and muscimol: a mushroom, not a plant, not a cannabinoid
- Functional mushroom blends (lion's mane, reishi, cordyceps, and similar)
None of these are hemp. None are cannabinoids. H.R. 5371 has no authority over them. Their legal status comes from entirely different regulatory frameworks, and nothing in this bill changes that.
Why Wunder's products are fully compliant
Wunder's gummies don't contain delta-8, delta-10, HHC, THCa, or any hemp-derived cannabinoid. They never did.
Wunder's formula is built around a botanical blend: kava root extract, blue lotus flower, and kanna extract. Some formulas also include amanita muscaria extract standardized to muscimol content. These are the active ingredients. No hemp-derived cannabinoid appears in the product at any concentration.
This wasn't a recent pivot made to dodge H.R. 5371. It's how Wunder was designed from the start. When the law changes the rules for delta-8 and HHC products, those changes simply don't reach a product that never contained those compounds.
If you want the legal and regulatory details on amanita muscaria specifically, the complete guide to amanita muscaria gummies covers federal status, state-by-state notes, and what to look for on a COA. For kava and blue lotus, the blue lotus guide goes deeper on how those compounds work and why they sit entirely outside the hemp regulatory space.
What to do if your current brand disappears from shelves
If you've been buying delta-8 or HHC gummies, November 2026 is a real deadline to find alternatives. Some brands will reformulate. Many won't survive the transition.
Three things to watch for as you look around:
Read the ingredient list, not the marketing copy. A product that switched from delta-8 to "hemp extract" without specifying what that means is probably still a cannabinoid product. Look for specific named ingredients: kava, blue lotus, kanna, or muscimol. Vague "botanical blend" language with no milligram breakdown deserves scrutiny.
Third-party testing still matters. Any reputable botanical product should have a COA from an independent lab. For muscimol products, look for muscimol content confirmed in milligrams per serving, plus low ibotenic acid. For kava, look for kavalactone percentage.
The effects are different from what you're used to. Kava and blue lotus don't produce a cannabis-like high. They produce something closer to a calming, mood-lifting effect. Read about what amanita actually feels like before you buy. The experience is distinct from both cannabis and classical psychedelics, and knowing what you're getting into helps you dose correctly.
Want to try Wunder's formula? The high-potency gummy lineup has COAs available for every product, clearly labeled ingredients, and no hemp-derived cannabinoid loopholes to worry about.
Frequently asked questions
Are mushroom gummies affected by the 2026 hemp law?
No. H.R. 5371 targets hemp-derived cannabinoids like delta-8, HHC, and THCa. Mushroom gummies made from amanita muscaria extract or functional mushroom blends don't contain hemp-derived cannabinoids and fall outside the bill entirely.
Are Wunder's gummies legal after November 2026?
Yes. Wunder's formula is built from botanical ingredients, not hemp-derived cannabinoids. H.R. 5371 does not affect Wunder's products.
What does H.R. 5371 ban exactly?
Hemp-derived intoxicants above 0.3% THC equivalent, including delta-8 THC, delta-10 THC, HHC, HHC-O, and THCa (after decarboxylation). Enforcement begins November 12, 2026.
Is kava legal in 2026?
Yes. Kava is not a hemp-derived cannabinoid and is not regulated under H.R. 5371 or any federal controlled substance scheduling. It's sold as a dietary supplement in most US states.
Is amanita muscaria legal in 2026?
In most states, yes. Amanita muscaria and muscimol are not DEA-scheduled substances. They are not affected by H.R. 5371. Louisiana restricts amanita muscaria specifically, so check your state's laws before purchasing.
Will delta-8 gummies still be available after November 2026?
Under federal law, no. After November 12, 2026, delta-8 and similar hemp-derived intoxicants will be prohibited. Federal enforcement will make most distribution channels non-viable.
What makes Wunder's gummies different from delta-8 products?
The active ingredients are entirely different. Delta-8 products work via THC-receptor binding (CB1). Wunder's formula uses kava (GABA-A modulation), blue lotus, kanna (serotonin reuptake inhibition), and optionally muscimol (also GABA-A). Different mechanism, different effect profile, different legal category.
